Blog

(From : http://feeds.feedburner.com - October 14 , 2019 )

By Kevin E.

(From : http://feeds.feedburner.com - October 14 , 2019 )

The Federal Circuit’s decision in In re HTC Corp., 889 F.3d 1349 (Fed. Cir. 2018), considered whether the TC Heartland decision extended to foreign defendants to afford them the protections of the special patent venue statute, 28 U.S.C.

(From : http://feeds.feedburner.com - October 14 , 2019 )

On October 9, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision in HZNP Medicines LLC v. Actavis Laboratories UT, Inc. affirming the U.S.

(From : http://feeds.feedburner.com - October 14 , 2019 )

This week in the nation’s capital, subcommittees in the House of Representatives will hold a series of technology-related hearings focused on online competition in data privacy, artificial intelligence (AI) and cloud computing in the financial sec

(From : http://feeds.feedburner.com - October 14 , 2019 )

The U.S. District Court for the Central District of California recently issued a decision in the closely watched Patagonia, Inc. v. Anheuser-Busch, LLC, 19-CV-02702 case.

(From : http://feeds.feedburner.com - October 14 , 2019 )

By Donald Zuhn -- Earlier this month, in Aker Biomarine Antarctic AS v. Rimfrost AS, the Federal Circuit affirmed two final written decisions by the U.S. Patent and Trademark Office Patent Trial and Appeal Board finding claims 1-19 of U.S.

(From : http://feeds.feedburner.com - October 13 , 2019 )

Here we go again! Another day, another ridiculous attack on the U.S. patent system.

(From : http://feeds.feedburner.com - October 12 , 2019 )

Insurance is a highly regulated field. New approaches to innovation are sorely needed. The need for innovation itself is undeniable as the tech world runs head long into the world of insurance.

(From : http://feeds.feedburner.com - October 11 , 2019 )

This past week in Other Barks & Bites: the Federal Circuit issued precedential decisions affirming the invalidation of patent claims covering osteoarthritis treatments and a costs award to Facebook, but reversed the PTAB on a reasonable expect